# Health Canada authorized 16 new prescription drugs and 540 devices in Q3

> The regulator also authorized 33 generic and biosimilar drugs from July to September and proposed shorter reviews for medicines for children.

- Canonical URL: https://newsverum.com/en/news/canada-health-product-authorizations-q3-2026
- Publisher: Newsverum
- Section: Health
- Country: Canada
- Published: 2026-10-16T16:20:29+00:00
- Updated: 2026-10-16T16:20:29+00:00
- Event / data period: 2026-09
- Other editions: [Türkçe](https://newsverum.com/tr/news/canada-health-product-authorizations-q3-2026.md), [العربية](https://newsverum.com/ar/news/canada-health-product-authorizations-q3-2026.md), [Français](https://newsverum.com/fr/news/canada-health-product-authorizations-q3-2026.md), [Español](https://newsverum.com/es/news/canada-health-product-authorizations-q3-2026.md), [Deutsch](https://newsverum.com/de/news/canada-health-product-authorizations-q3-2026.md), [Português](https://newsverum.com/pt/news/canada-health-product-authorizations-q3-2026.md)

Health Canada reported that it authorized 16 new prescription drugs, 33 generic or biosimilar drugs and 540 new medical devices from July 1 through September 30, 2026. Its quarterly update on October 15 also described pressure on the drug-review process from a growing number of increasingly complex submissions.

The department is prioritizing some generic submissions and advancing changes to clinical-trial rules. A proposed approach for medicines for children and youth would shorten review times from 300 days to as few as 180; the proposal remained under consultation through October 23 and was not a finalized rule.

## Data

### Health Canada Q3 2026 authorizations

Counts of drugs and medical devices authorized from July 1 through September 30, 2026.

Methodology: Counts are taken from Health Canada’s quarterly release dated October 15, 2026; only categories stated in the source are shown.

| label | value | unit | period | basis |
|---|---|---|---|---|
| New prescription drugs | 16 | count | 2026-09 | observed |
| Generic and biosimilar drugs | 33 | count | 2026-09 | observed |
| New medical devices | 540 | count | 2026-09 | observed |

Sources: <https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html> · Download data: [JSON](https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=en&format=csv)

## Sources

- [Health Canada](<https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html>) (Source checked: 2026-10-16; Published: 2026-10-15)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)